Over 135 Healthcare Companies to Present at Roth Capital Partners 23rd Annual OC Growth Stock Conference March 13-16, 2011

Largest ROTH Conference to Date Will Showcase Record Number of Innovative Companies in Biotech, Pharma and Medical Technology

2011 ROTH OC Conference

NEWPORT BEACH, Calif.--()--ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank recognized for providing financing and advisory services to emerging growth companies worldwide, today confirmed that over 135 leading biotechnology, specialty pharma and medical technology companies will be featured at its 23rd Annual OC Growth Stock Conference. This invitation-only conference with more than 430 presenting companies will be held March 13-16, 2011 at The Ritz Carlton, located at 1 Ritz Carlton Drive, Dana Point, California.

“As one of the largest and fastest growing sectors of the economy, the healthcare sector is highly attractive to investors seeking outsized returns. The sector overall has benefitted from increased investor interest and heightened capital markets activity throughout 2010, which we see continuing into 2011,” said John Chambers, ROTH Managing Director and Head of Healthcare Investment Banking. “This conference serves as an ideal venue for company management to interact with the investors that will provide both capital and support as they continue to grow, and for investors to explore the opportunities being targeted by an extremely innovative group of select companies.”

Since January 2010, ROTH has executed approximately 46 healthcare financings, raising over $1 billion for its clients, and has significantly increased its market position in funding life sciences companies.

Scott Henry, CFA, Head of Healthcare Research at ROTH, said, "Our annual conference provides investors unparalleled access to company management and the opportunity to hear about the latest innovations from a wide spectrum of cutting-edge companies spanning the life sciences sector. Participants can attend one-on-one sessions, moderated company presentations and interactive panels led by industry professionals, clinical experts and academics. In addition, the unique conference setting and agenda, which includes evening programs, is highly conducive to the fostering of informal interactions and discussions among attendees."

This year’s featured healthcare panel sessions will be on “Hot Targets in Oncology”, held on Monday, March 14th, and “Antibacterials”, held on Tuesday March 15th.

The three-day, institutional investor conference will be the largest ROTH conference to date and feature management presentations from companies representing a broad spectrum of sectors including: Healthcare, Media & Internet, Enterprise Software, Gaming, Semiconductors, Global Energy and Industrials and Retail & Consumer. The agenda will also include a China Track with over 100 China-based companies represented.

A partial list of conference sponsors at the time of this announcement includes:

PLATINUM

AFH Holding & Advisory
Crowe Horwath
DLA Piper US LLP
Friedman LLP
Loeb & Loeb
Lowenstein Sandler PC
Marcum Bernstein & Pinchuk LLP
Thomson Reuters
William O'Neil + Co
Willis

GOLD

Anslow + Jaclin LLP
Business Wire
Capital IQ
Goodwin Procter LLP
K&L Gates
Latham & Watkins LLP
OTC Markets Inc.
Pillsbury Winthrop Shaw Pittman LLP
Rothstein Kass
Sichenzia Ross Friedman Ference LLP
SingerLewak
Stradling Yocca Carlson & Rauth
Vintage Filings

SILVER

Avantair
BIOCOM
CCG Investor Relations
China Venture
CleanTech OC
Continental Stock Transfer & Trust Company
Corporate Stock Transfer
Dorsey & Dorsey
EFP Rotenberg LLP
FTI Consulting
Forefront Capital
Grant Thornton LLP
iChinaStock.com
Holtz Rubenstein Reminick LLP
Mayer Hoffman McCann P.C.
Moss Adams
NASDAQ OMX
NYSE Euronext
PrivateRaise/DealFlow Media
SEC Connect
Stroock & Stroock & Lavan LLP
The Piacente Group, Inc.
Wall Street Webcasting
Weinberg & Company
Weintraub Genshlea Chediak
Winston & Strawn LLP
KCSA

For more information about this invitation-only conference – including agenda, web cast schedule and a list of participating companies – please visit: www.roth.com.

About Roth Capital Partners, LLC:

ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on identifying opportunities for institutional investors in U.S.-listed equity securities of companies based in the U.S. and China. Headquartered in Newport Beach, CA, with offices throughout the U.S., Hong Kong and a Shanghai Representative Office, the employee-owned firm provides analytical research, trading, capital raising, and business combination advisory services. ROTH seeks to implement innovative financing strategies to efficiently meet the liquidity and valuation requirements of both its corporate and institutional investor clients.

Key Words:

Small-Cap Stocks
Micro-Cap Stocks
PIPEs
Media
Energy
Software
Industrials
Media
Retail
Technology
Healthcare
Financial Services
Consumer Goods
China
Institutional Investor
Medical Devices
Spec Pharma
Pharmaceuticals
Generics
Drug Delivery
Biotechnology
Registered Direct

Contacts

INVESTOR CONTACT:
ROTH Capital Partners
Isabel Mattson-Pain, 949-720-7117
Director of Marketing
Imattson-pain@roth.com
or
MEDIA CONTACT:
Kekst and Company
Lin-Hua Wu, 415-391-4665
lin-wu@kekst.com

Release Summary

ROTH confirmed that over 135 leading biotechnology, specialty pharma and medical technology companies will be featured at its 23rd Annual OC Growth Stock Conference on March 13-16, 2011.

Sharing

Contacts

INVESTOR CONTACT:
ROTH Capital Partners
Isabel Mattson-Pain, 949-720-7117
Director of Marketing
Imattson-pain@roth.com
or
MEDIA CONTACT:
Kekst and Company
Lin-Hua Wu, 415-391-4665
lin-wu@kekst.com